21 Oct 2022 --- This week in personal care news, Evolva received US$540,000 from the US Centers for Disease Control and Prevention (CDC) to develop nature-based and effective products for protection against vector-borne diseases from insects and ticks. The New York Stock Exchange (NYSE) announced a decision to suspend and remove Revlon from trading in the Class A Common Stock and will now file a delisting application with the Securities and Exchange Commission. Meanwhile, Upkeep announced a US$2 million seed funding to accelerate growth and expand to new markets.
